BioLumic

Palmerston North, New Zealand · Founded 2012 · Privately Held (backing)

Developer of an ultraviolet crop improvement system designed to address growing agricultural concerns. BioLumic is based in Palmerston North, New Zealand and was founded in 2012. It was valued at $69 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $32.6 million across 2 recorded rounds; the latest was a $12.5 million early-stage round in Mar 2022.

PMV mark · valuation
$69.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$32.6M
Last round
Early Stage VC
Mar 2022
What is BioLumic worth?
$69.0MPrivateMarketView mark · Oct 2026

Valued at $69.0M at its later-stage round, Apr 2025. Nothing has traded since.

Free account
More of BioLumic with a free account
  • ·The complete investor list: 34 names
  • ·Watch BioLumic: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

BioLumic funding history

2 rounds
DateRoundRaisedPost-money
Mar 2022Early Stage VC$12.5M▮
Nov 2021Debt$1.3M▮
Unlock post-money valuations

Membership and data by Private Market View

BioLumic valuation

BioLumic was valued at $69 million at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has BioLumic raised?

BioLumic has raised $32.6 million in total; 2 of its rounds are on record. The largest on record was a $1.3 million debt round in Nov 2021; the most recent was a $12.5 million early-stage round in Mar 2022.

BioLumic has filed 2 Form Ds with the SEC since 2021, most recently in Mar 2022 ($12.5 million sold to 25 investors).

How BioLumic's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For BioLumic, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about BioLumic

What is BioLumic worth?
BioLumic is valued at $69.0M as of Oct 2026. Valued at $69.0M at its later-stage round, Apr 2025. Nothing has traded since.
How much has BioLumic raised?
BioLumic has raised $32.6M in total funding across 2 recorded rounds.
When did BioLumic last raise?
BioLumic last raised in Mar 2022 (Early Stage VC), raising $12.5M.